IL18 and neoplasm: It may act as a tumor suppressor in certain settings—for instance, via truncated isoforms that inhibit the oncogenic activity of the full-length protein—or alternatively promote tumor progression by enhancing cell migration, potentially through Interleukin 18 (IL-18)–mediated mechanisms [89,90,91,92,93].